- Home
- GALT vs MBINM Comparison
GALT vs MBINM Comparison
Compare GALT & MBINM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- MBINM
- Stock Information
- Founded
- GALT 2000
- MBINM N/A
- Country
- GALT United States
- MBINM United States
- Employees
- GALT N/A
- MBINM 618
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- MBINM Major Banks
- Sector
- GALT Health Care
- MBINM Finance
- Exchange
- GALT Nasdaq
- MBINM Nasdaq
- Market Cap
- GALT 147.8M
- MBINM N/A
- IPO Year
- GALT N/A
- MBINM N/A
- Fundamental
- Price
- GALT $1.04
- MBINM $25.92
- Analyst Decision
- GALT Strong Buy
- MBINM
- Analyst Count
- GALT 1
- MBINM 0
- Target Price
- GALT $11.00
- MBINM N/A
- AVG Volume (30 Days)
- GALT 1.1M
- MBINM N/A
- Earning Date
- GALT 11-13-2024
- MBINM N/A
- Dividend Yield
- GALT N/A
- MBINM N/A
- EPS Growth
- GALT N/A
- MBINM N/A
- EPS
- GALT N/A
- MBINM N/A
- Revenue
- GALT N/A
- MBINM N/A
- Revenue This Year
- GALT N/A
- MBINM N/A
- Revenue Next Year
- GALT N/A
- MBINM N/A
- P/E Ratio
- GALT N/A
- MBINM N/A
- Revenue Growth
- GALT N/A
- MBINM N/A
- 52 Week Low
- GALT $0.73
- MBINM N/A
- 52 Week High
- GALT $4.27
- MBINM N/A
- Technical
- Relative Strength Index (RSI)
- GALT 20.80
- MBINM 45.91
- Support Level
- GALT $1.80
- MBINM $25.55
- Resistance Level
- GALT $2.36
- MBINM $26.92
- Average True Range (ATR)
- GALT 0.27
- MBINM 0.24
- MACD
- GALT -0.08
- MBINM -0.07
- Stochastic Oscillator
- GALT 15.07
- MBINM 27.01
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About MBINM Merchants Bancorp
Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and Banking segment that provides a wide range of financial products and services to consumers and businesses, including commercial and other consumer loan products.